Literature DB >> 26081639

Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system.

Valeria Ricotti1, Herbert Jägle2, Maria Theodorou3, Anthony T Moore3, Francesco Muntoni1, Dorothy A Thompson3.   

Abstract

Multiple isoforms of dystrophin (Dp427, Dp260, Dp140, Dp71) are expressed differentially in the central nervous system (CNS) including the retinal layers. Disruption of these protein products is responsible for cognitive dysfunction, electroretinogram (ERG) abnormalities and behavioural disorders in Duchenne muscular dystrophy (DMD). We studied the ocular characteristics and neuropsychiatric profile of 16 DMD boys. The ISCEV standard, full-field flash ERGs were assessed. Intellectual ability and behavioural disturbances were measured. All genotypes were associated with mildly abnormal photopic ERG a:b-wave amplitude ratios. In addition, we identified the following genotype/phenotype correlations: boys with mutations upstream of exon 30 (ie, isolated Dp427 altered expression) showed normal scotopic a:b ratios, abnormal photopic oscillatory potential OP2 and normal scotopic OP2. Conversely, all boys with DMD mutations downstream of exon 30 showed profoundly 'negative' scotopic ERGs (a:b ratios >1). In these patients, the involvement of Dp260 isoform resulted in the absence of slow rod pathway signalling in15 Hz scotopic flicker ERGs. These boys had abnormal scotopic OP2 and normal photopic OP2. Finally, children with mutations also affecting Dp71 were associated with more pronounced electronegative ERGs. When correlating ERGs to neurodevelopmental outcome, we found a positive correlation between negative scotopic ERGs and neurodevelopmental disturbances, and the most severe findings were in boys with Dp71 disruption. These findings suggest a strong association between DMD mutations affecting different DMD isoforms with characteristically abnormal scotopic ERGs and severe neurodevelopmental problems. The role of the ERG as a potential biomarker for dystrophin function in the CNS and response to novel genetic therapies warrants further exploration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26081639      PMCID: PMC4929863          DOI: 10.1038/ejhg.2015.135

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  47 in total

1.  Dystrophin and the brain.

Authors:  Valeria Ricotti; Roland G Roberts; Francesco Muntoni
Journal:  Dev Med Child Neurol       Date:  2011-01       Impact factor: 5.449

2.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

3.  195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands.

Authors:  Juliet A Ellis; Elizabeth Vroom; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2013-06-20       Impact factor: 4.296

Review 4.  Dystrophin, its interactions with other proteins, and implications for muscular dystrophy.

Authors:  James M Ervasti
Journal:  Biochim Biophys Acta       Date:  2006-06-07

5.  Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse.

Authors:  Glenn Dallérac; Caroline Perronnet; Carine Chagneau; Pascale Leblanc-Veyrac; Nathalie Samson-Desvignes; Elise Peltekian; Olivier Danos; Luis Garcia; Serge Laroche; Jean-Marie Billard; Cyrille Vaillend
Journal:  Neurobiol Dis       Date:  2011-05-23       Impact factor: 5.996

6.  Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression.

Authors:  Fatma Daoud; Nathalie Angeard; Bénédicte Demerre; Itxaso Martie; Rabah Benyaou; France Leturcq; Mireille Cossée; Nathalie Deburgrave; Yoann Saillour; Sylvie Tuffery; Andoni Urtizberea; Annick Toutain; Bernard Echenne; Martine Frischman; Michèle Mayer; Isabelle Desguerre; Brigitte Estournet; Christian Réveillère; Jean Marie Cuisset; Jean Claude Kaplan; Delphine Héron; François Rivier; Jamel Chelly
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

Review 7.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

8.  Social communication competence and functional adaptation in a general population of children: preliminary evidence for sex-by-verbal IQ differential risk.

Authors:  David H Skuse; William Mandy; Colin Steer; Laura L Miller; Robert Goodman; Kate Lawrence; Alan Emond; Jean Golding
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-02       Impact factor: 8.829

9.  Dystrophins in developing retina: Dp260 expression correlates with synaptic maturation.

Authors:  F Rodius; T Claudepierre; H Rosas-Vargas; B Cisneros; C Montanez; H Dreyfus; D Mornet; A Rendon
Journal:  Neuroreport       Date:  1997-07-07       Impact factor: 1.837

10.  Early neurodevelopmental assessment in Duchenne muscular dystrophy.

Authors:  Marika Pane; Roberta Scalise; Angela Berardinelli; Grazia D'Angelo; Valeria Ricotti; Paolo Alfieri; Isabella Moroni; Louise Hartley; Maria Carmela Pera; Giovanni Baranello; Michela Catteruccia; Tiziana Casalino; Domenico M Romeo; Alessandra Graziano; Claudia Gandioli; Flaviana Bianco; Elena Stacy Mazzone; Maria Elena Lombardo; Mariacristina Scoto; Serena Sivo; Concetta Palermo; Francesca Gualandi; Maria Pia Sormani; Alessandra Ferlini; Enrico Bertini; Francesco Muntoni; Eugenio Mercuri
Journal:  Neuromuscul Disord       Date:  2013-03-25       Impact factor: 4.296

View more
  12 in total

1.  Repurposing Pathogenic Variants of DMD Gene and its Isoforms for DMD Exon Skipping Intervention.

Authors:  Rahul Tyagi; Sumit Kumar; Ashwin Dalal; Faruq Mohammed; Manju Mohanty; Paramvir Kaur; Akshay Anand
Journal:  Curr Genomics       Date:  2019-11       Impact factor: 2.236

2.  Intronic Alternative Polyadenylation in the Middle of the DMD Gene Produces Half-Size N-Terminal Dystrophin with a Potential Implication of ECG Abnormalities of DMD Patients.

Authors:  Abdul Qawee Mahyoob Rani; Tetsushi Yamamoto; Tatsuya Kawaguchi; Kazuhiro Maeta; Hiroyuki Awano; Hisahide Nishio; Masafumi Matsuo
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 3.  Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine.

Authors:  Domenico D'Amario; Aoife Gowran; Francesco Canonico; Elisa Castiglioni; Davide Rovina; Rosaria Santoro; Pietro Spinelli; Rachele Adorisio; Antonio Amodeo; Gianluca Lorenzo Perrucci; Josip A Borovac; Giulio Pompilio; Filippo Crea
Journal:  J Clin Med       Date:  2018-09-19       Impact factor: 4.241

4.  Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A.

Authors:  M S Alexander; M J Gasperini; P T Tsai; D E Gibbs; J M Spinazzola; J L Marshall; M J Feyder; M T Pletcher; E L P Chekler; C A Morris; M Sahin; J F Harms; C J Schmidt; R J Kleiman; L M Kunkel
Journal:  Transl Psychiatry       Date:  2016-09-27       Impact factor: 6.222

Review 5.  Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.

Authors:  Masafumi Matsuo; Hiroyuki Awano; Masaaki Matsumoto; Masashi Nagai; Tatsuya Kawaguchi; Zhujun Zhang; Hisahide Nishio
Journal:  Genes (Basel)       Date:  2017-10-02       Impact factor: 4.096

6.  Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy.

Authors:  Nathalie Doorenweerd; Ahmed Mahfouz; Maaike van Putten; Rajaram Kaliyaperumal; Peter A C T' Hoen; Jos G M Hendriksen; Annemieke M Aartsma-Rus; Jan J G M Verschuuren; Erik H Niks; Marcel J T Reinders; Hermien E Kan; Boudewijn P F Lelieveldt
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

7.  Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71.

Authors:  Mirella Telles Salgueiro Barboni; Cyrille Vaillend; Anneka Joachimsthaler; André Maurício Passos Liber; Hanen Khabou; Michel J Roux; Ophélie Vacca; Lucile Vignaud; Deniz Dalkara; Xavier Guillonneau; Dora Fix Ventura; Alvaro Rendon; Jan Kremers
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

8.  Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM.

Authors:  Dao Wei Zhang; Shenghai Zhang; Jihong Wu
Journal:  PeerJ       Date:  2020-09-03       Impact factor: 2.984

9.  Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy.

Authors:  Elisabetta Catalani; Silvia Bongiorni; Anna Rita Taddei; Marta Mezzetti; Federica Silvestri; Marco Coazzoli; Silvia Zecchini; Matteo Giovarelli; Cristiana Perrotta; Clara De Palma; Emilio Clementi; Marcello Ceci; Giorgio Prantera; Davide Cervia
Journal:  Cell Mol Life Sci       Date:  2020-08-04       Impact factor: 9.261

10.  Transsynaptic Binding of Orphan Receptor GPR179 to Dystroglycan-Pikachurin Complex Is Essential for the Synaptic Organization of Photoreceptors.

Authors:  Cesare Orlandi; Yoshihiro Omori; Yuchen Wang; Yan Cao; Akiko Ueno; Michel J Roux; Giuseppe Condomitti; Joris de Wit; Motoi Kanagawa; Takahisa Furukawa; Kirill A Martemyanov
Journal:  Cell Rep       Date:  2018-10-02       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.